S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
NASDAQ:IMUX

Immunic Earnings Date, Estimates, & History

$8.67
+0.28 (+3.34 %)
(As of 10/15/2021 04:00 PM ET)
Add
Compare
Today's Range
$8.30
$8.70
50-Day Range
$7.34
$10.23
52-Week Range
$6.96
$28.21
Volume192,524 shs
Average Volume217,490 shs
Market Capitalization$227.58 million
P/E RatioN/A
Dividend YieldN/A
Beta2.03

Earnings Summary

Upcoming
Earnings Date
Nov. 4
Estimated

Actual EPS
(Aug. 6)
-$0.82
Missed By -$0.14

Consensus EPS
(Aug. 6)
-$0.68

Last Year's Q3 EPS
(8/2/2020)
-$0.90

Skip Charts & View Estimated and Actual Earnings Data

Immunic Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Immunic Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Immunic (NASDAQ:IMUX) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212($0.72)($0.64)($0.68)
Q2 20212($0.78)($0.65)($0.72)
Q3 20212($0.85)($0.77)($0.81)
Q4 20212($0.87)($0.82)($0.85)
FY 20218($3.22)($2.88)($3.05)
Q1 20222($0.94)($0.91)($0.93)
Q2 20222($1.00)($0.93)($0.97)
Q3 20222($1.10)($0.93)($1.02)
Q4 20222($1.36)($1.20)($1.28)
FY 20228($4.40)($3.97)($4.19)

IMUX Earnings Information

Immunic last announced its earnings data on August 6th, 2021. The reported ($0.82) earnings per share for the quarter, missing analysts' consensus estimates of ($0.68) by $0.14. Immunic has generated ($2.81) earnings per share over the last year (($3.61) diluted earnings per share). Earnings for Immunic are expected to grow in the coming year, from ($3.91) to ($3.60) per share. Immunic has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 4th, 2021 based off prior year's report dates.

Immunic (NASDAQ:IMUX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
11/4/2021
(Estimated)
        
8/6/20216/30/2021($0.68)($0.82)($0.14)($0.82)
5/6/20213/31/2021($0.71)($1.63)($0.92)($1.63)  
2/26/2021Q4 2020($0.59)($0.46)+$0.13($0.46)
11/5/20209/30/2020($0.64)($0.70)($0.06)($0.70)  
8/2/2020Q2 2020($0.62)($0.90)($0.28)($0.90)
5/8/20203/31/2020($0.96)($0.79)+$0.17($0.79)
3/16/202012/31/2019($0.76)($0.56)+$0.20($0.56)
11/7/2019Q3($0.67)($0.82)($0.15)($0.82)
8/8/2019Q2 2019($0.7250)($1.52)($0.7950)($1.52)
4/10/2019Q1 2019($8.80)($8.80)($8.80)
3/4/2019Q4 2018($2.40)($2.40)($2.40)
11/7/2018Q3 2018($11.20)($11.20)($11.20)
8/7/2018Q2 2018($13.20)($12.00)+$1.20($12.00)
5/8/2018Q1 2018($13.60)($13.60)($13.60)
3/13/2018Q4 2017($12.00)($14.00)($2.00)($14.00)
10/25/2017Q3 2017($12.00)($12.00)($12.00)
8/3/2017Q2 2017($12.00)($11.60)+$0.40($11.60)
5/9/2017Q1 2017($14.80)($15.60)($0.80)($15.60)
3/7/2017Q4 2016($13.20)($14.80)($1.60)($14.80)
11/3/2016Q3 2016($12.80)($12.80)($12.80)
8/2/2016Q2 2016($12.80)($12.00)+$0.80($12.00)
5/9/2016Q1 2016($12.80)($12.40)+$0.40($12.40)
3/8/2016Q4 2015($16.40)($13.60)+$2.80($13.60)
11/5/2015Q3 2015($24.40)($20.40)+$4.00($20.40)
7/30/2015Q2 2015($25.60)($25.20)+$0.40($25.20)
5/12/2015Q1 2015($24.00)($24.80)($0.80)($24.80)
3/19/2015Q4 2014($24.00)($23.60)+$0.40($23.60)
11/13/2014Q3 2014($25.60)($23.60)+$2.00($23.60)
8/6/2014Q2 2014($24.00)($36.40)($12.40)($36.40)
5/28/2014Q1 2014($21.60)($979.60)($958.00)($979.60)
(Earnings results data provided by Zacks Investment Research)












Immunic (NASDAQ:IMUX) Earnings Frequently Asked Questions

When is Immunic's earnings date?

Immunic has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 4th, 2021 based off last year's report dates. Learn more on IMUX's earnings history

Did Immunic beat their earnings estimates last quarter?

In the previous quarter, Immunic (NASDAQ:IMUX) missed the analysts' consensus estimate of ($0.68) by $0.14 with a reported earnings per share (EPS) of ($0.82). Learn more on IMUX's earnings details

How much profit does Immunic generate each year?

Immunic (NASDAQ:IMUX) has a recorded net income of -$44.02 million. IMUX has generated -$2.81 earnings per share over the last four quarters.

What is Immunic's EPS forecast for next year?

Immunic's earnings are expected to grow from ($3.91) per share to ($3.60) per share in the next year.

This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.